Vikas Gupta MD, FRCP, FRCPath
Dr. Gupta is site lead for the Elizabeth and Tony Comper MPN Program, and a member of the Leukemia/MPN Program at Princess Margaret Cancer Centre. He is the founding member and president of the Canadian MPN Group. His clinical and research activities are focused on developing novel transplant and non-transplant based treatment strategies for patients with myeloid malignancies, in particular myeloproliferative neoplasms.
Dawn Maze MD, FRCPC,
MSc Having completed her Medical Degree and Internal Medicine training at Memorial University, Dr. Maze did a Hematology Fellowship at Queen’s University during which time she completed a Master of Science in Clinical Epidemiology. She joined the Leukemia Program at the Princess Margaret Cancer Centre in 2016. Her research activities are focused on optimizing transfusion practices.
Hassan Sibai MD, FRCPC
After completing a fellowship at the American University of Beirut in Lebanon, he joined the Leukemia Program at the Princess Margaret Cancer Centre as a fellow, where he is now a Staff Physician in the Leukemia Program. Dr. Sibai actively sees patients referred to the MPN Program and has a focus in innovations in malignant hematology education
Auro Viswabandya MD, DM
Dr. Viswabandya currently is a staff physician in Allogeneic Stem Cell Transplantation division at the Princess Margaret Cancer Centre and Assistant Professor, Department of Medicine at the University of Toronto. He is actively involved in allogeneic stem cell transplantation in patients with myeloproliferative syndromes. His clinical and research activities are focused on haploidentical stem cell transplantation in patients with hematological malignancies.